Home/Filings/4/0001181431-12-005855
4//SEC Filing

MARTIN J TYLER 4

Accession 0001181431-12-005855

CIK 0001029142other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 5:53 PM ET

Size

5.4 KB

Accession

0001181431-12-005855

Insider Transaction Report

Form 4
Period: 2012-02-01
MARTIN J TYLER
VP Clinical Development & CMO
Transactions
  • Award

    Option (Right to Buy)

    2012-02-01+400,000400,000 total
    Exercise: $3.68Exp: 2022-01-31Common Stock (400,000 underlying)
Footnotes (2)
  • [F1]This option grant shall vest over four (4) years with one fourth (1/4) of the Shares subject to the Option vesting twelve months after the Vesting Commencement Date, and one forty-eighth (1/48) of the Shares subject to the Option vesting on the last day of each month thereafter.
  • [F2]Not applicable.

Issuer

DYNAVAX TECHNOLOGIES CORP

CIK 0001029142

Entity typeother

Related Parties

1
  • filerCIK 0001234388

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:53 PM ET
Size
5.4 KB